CPAP and NIPPV no better than O2 in acute pulmonary edema (3CPO)

General

Clinical Question:
Does noninvasive ventilation improve outcomes in patients with acute cardiogenic pulmonary edema?

Bottom Line:
In patients with acute cardiogenic pulmonary edema, continuous positive airway pressure (CPAP) and noninvasive positive pressure support (NIPPV) do not reduce mortality or the risk of requiring intubation more than standard oxygen therapy. They may provide a small benefit in terms of greater relief of dyspnea. (LOE = 1b)

Reference:
Gray A, Goodacre S, Newby DE, et al, for the 3CPO Trialists. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med 2008;359(2):142-151.  [PMID:18614781]

Study Design:
Randomized controlled trial (nonblinded)

Allocation:
Concealed

Setting:
Inpatient (any location)

Synopsis:
The optimal approach to noninvasive ventilation for patients with acute cardiogenic pulmonary edema remains unclear, with only a few small randomized controlled trials. CPAP provides the same level of positive airway pressure throughout the respiratory cycle, while NIPPV increases pressure more during inspiration than during expiration. There are theoretical reasons to think that NIPPV may be better, but it has also been associated with a greater risk of acute myocardial infarction. In this study, 1069 adults with acute cardiogenic pulmonary edema at 26 United Kingdom emergency departments were randomized to receive oxygen therapy, CPAP, or NIPPV. All patients had pulmonary edema on chest x-ray, a pH of less than 7.35, and a respiratory rate greater than 20 breaths per minute. Their mean age was 78 years and 57% were women. All patients received the assigned treatment for at least 2 hours, with the duration of further treatment determined by the treating physician. Groups were balanced at the start of the study and analysis was by intention to treat. Overall adherence to the assigned treatment was good, although patients initially assigned to oxygen were more likely to change therapy because of respiratory distress (8.4% vs 1.4% for CPAP and 3.4% for NIPPV; P < .001), while those assigned to NIPPV were more likely to change therapy because of patient discomfort (8.4% vs 5.2% for CPAP and 0.3% for oxygen; P < .001). After 7 days, there was no significant difference between groups regarding rates of mortality or need for intubation, or regarding mortality at 30 days. Patients receiving CPAP or NIPPV had a greater improvement on a 10-point dyspnea score than those receiving oxygen alone (4.6 vs 3.9 points), but this difference is of questionable clinical significance. There were also greater improvements in arterial pCO2 and pH, but again the clinical significance is uncertain.

CPAP and NIPPV no better than O2 in acute pulmonary edema (3CPO) is a sample topic from the EE+ POEM Archive.

To view other topics, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Learn more.

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - CPAP and NIPPV no better than O2 in acute pulmonary edema (3CPO) ID - 426274 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426274/all/CPAP_and_NIPPV_no_better_than_O2_in_acute_pulmonary_edema__3CPO_ PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -